Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1973;47:1356-1363

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RESNEKOV, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RESNEKOV, L.

(Circulation. 1973;47:1356.)
© 1973 American Heart Association, Inc.


Present Status of Electroversion in the Management of Cardiac Dysrhythmias

LEON RESNEKOV 1

1 From the Department of Medicine, Section of Cardiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois.

The theoretical and practical considerations of electrical reversion of cardiac dysrhythmias are reviewed and a comparison made between AC and DC defibrillation, indicating the superiority of DC under all circumstances. The indications for, immediate and late results of DC shock for atrial and ventricular dysrhythmias are presented, the complication of such treatment reviewed, and the need for anticoagulant cover, anesthesia, and drug therapy preceding and following the electrical treatment discussed. Each patient requires individual assessment, particularly those with chronic rhythm disturbances, especially atrial fibrillation, in whom electrical energy settings in excess of 300 joules are rarely indicated for the risk of complications becomes progressively higher as the energy setting is increased and the length of time sinus rhythm persists in this group of patients may be short. Patients with acute rhythm disturbances, however, with potentially serious hemodynamic consequences should be treated with maximum electric energies if needed. Caution is also advised in patients with coronary heart disease, atrial fibrillation, and a slow ventricular rate, even in the absence of digoxin, patients with rapidly changing rhythm disturbances, those who cannot maintain sinus rhythm for a significant period of time despite drug therapy, patients with the "sick sinus syndrome," those with atrial fibrillation of more than 5 years standing with a cardiothoracic ratio exceeding 55%, and patients in lone atrial fibrillation. Heavily digitalized patients in general should have their electroversion postponed if possible, but if not, they should be protected against serious ventricular rhythm disturbances immediately after the shock by an intravenous dose of lidocaine, phenylhydantoin, or procaine amide immediately before and the initial energy setting should be reduced to 5 joules. Quinidine or some other antidysrhythmic drug may be needed in an attempt to maintain sinus rhythm after successful electroversion, but even when controlled with adequate blood levels, results are poor.


Key Words: AC defibrillation • Antidysrhythmic drugs • DC defibrillation • Digitalis • Sick sinus syndrome • Anticoagulants




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
J. Janssen, L. Loomans, J. Harink, M. Taams, L. Brunninkhuis, P. van der Starre, and G. Kootstra
Prevention and Treatment of Supraventricular Tachycardia Shortly After Coronary Artery Bypass Grafting: A Randomized Open Trial
Angiology, August 1, 1986; 37(8): 601 - 609.
[Abstract] [PDF]